{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T13:11:36Z","timestamp":1719407496361},"reference-count":45,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9303","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T06:59:44Z","timestamp":1534229984000},"source":"Crossref","is-referenced-by-count":5,"title":["Interleukin\u201115 suppresses gastric cancer liver metastases by enhancing natural killer cell activity in a murine model"],"prefix":"10.3892","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiejie","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faxiang","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwen","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"key20200714084003_b1-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3322\/caac.20143","article-title":"Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening","volume":"62","author":"Smith","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key20200714084003_b2-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"Sasako","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20200714084003_b3-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1067\/msy.2003.147","article-title":"Surgical resection of liver metastases of gastric cancer: An analysis of a 17-year experience with 22 patients","volume":"133","author":"Sakamoto","year":"2003","journal-title":"Surgery"},{"key":"key20200714084003_b4-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1002\/1097-0142(19850515)55:10<2498::AID-CNCR2820551032>3.0.CO;2-S","article-title":"Evaluation of treatment for gastric cancer with liver metastasis","volume":"55","author":"Okuyama","year":"1985","journal-title":"Cancer"},{"key":"key20200714084003_b5-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","article-title":"Patterns of initial recurrence in completely resected gastric adenocarcinoma","volume":"240","author":"D'Angelica","year":"2004","journal-title":"Ann Surg"},{"key":"key20200714084003_b6-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jso.20739","article-title":"Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer","volume":"95","author":"Sakamoto","year":"2007","journal-title":"J Surg Oncol"},{"key":"key20200714084003_b7-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00595-009-4152-0","article-title":"Strategies for treating liver metastasis from gastric cancer","volume":"40","author":"Kakeji","year":"2010","journal-title":"Surg Today"},{"key":"key20200714084003_b8-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1073\/pnas.91.11.4935","article-title":"A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine activated killer cells","volume":"91","author":"Burton","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714084003_b9-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1126\/science.8178155","article-title":"Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor","volume":"264","author":"Grabstein","year":"1994","journal-title":"Science"},{"key":"key20200714084003_b10-ol-0-0-9303","first-page":"457","article-title":"Interleukin 15: Its role in inflammation and immunity","volume":"48","author":"Perera","year":"2000","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"key20200714084003_b11-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cytogfr.2010.09.003","article-title":"Role of IL-15 in immune-mediated andinfectious diseases","volume":"22","author":"Di Sabatino","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20200714084003_b12-ol-0-0-9303","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4049\/jimmunol.154.2.483","article-title":"IL-15 has stimulatory activityfor the induction of B cell proliferation and differentiation","volume":"154","author":"Armitage","year":"1995","journal-title":"J Immunol"},{"key":"key20200714084003_b13-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1172\/JCI119258","article-title":"Apotential role for interleukin-15 in the regulation of human natural killer cell survival","volume":"99","author":"Carson","year":"1997","journal-title":"J Clin Invest"},{"key":"key20200714084003_b14-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-065X.1995.tb00091.x","article-title":"Common cytokine receptor chain (c)-dependent cytokines: Understanding in vivo functions by gene targeting","volume":"148","author":"Di Santo","year":"1995","journal-title":"Immunol Rev"},{"key":"key20200714084003_b15-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4049\/jimmunol.167.1.1","article-title":"Cutting edge: The common -chain is an indispensable subunit of the IL-21 receptor complex","volume":"167","author":"Asao","year":"2001","journal-title":"J Immunol"},{"key":"key20200714084003_b16-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1189\/jlb.0909648","article-title":"IL-15 has innate anti-tumor activity independent of NK and CD8 T cells","volume":"88","author":"Davies","year":"2010","journal-title":"J Leukoc Biol"},{"key":"key20200714084003_b17-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1073\/pnas.0630592100","article-title":"Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity","volume":"100","author":"Oh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714084003_b18-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/cimm.1995.1216","article-title":"Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: Comparison with interleukin-2","volume":"165","author":"Munger","year":"1995","journal-title":"Cell Immunol"},{"key":"key20200714084003_b19-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tips.2011.09.004","article-title":"Interleukin-15 biology and its therapeutic implications in cancer","volume":"33","author":"Steel","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"key20200714084003_b20-ol-0-0-9303","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast","volume":"8","author":"Paget","year":"1889","journal-title":"Cancer Metastasis Rev"},{"key":"key20200714084003_b21-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/j.1460-2075.1994.tb06576.x","article-title":"Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15","volume":"13","author":"Giri","year":"1994","journal-title":"EMBO J"},{"key":"key20200714084003_b22-ol-0-0-9303","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","article-title":"Interleukin-15 is an autocrine\/paracrine viability factor for cutaneous T-cell lymphoma cells","volume":"92","author":"D\u00a8obbeling","year":"1998","journal-title":"Blood"},{"key":"key20200714084003_b23-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1089\/hum.2007.0171","article-title":"Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2","volume":"19","author":"Heemskerk","year":"2008","journal-title":"Hum Gene Ther"},{"key":"key20200714084003_b24-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/cncr.23552","article-title":"High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: A retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006","volume":"113","author":"Klapper","year":"2008","journal-title":"Cancer"},{"key":"key20200714084003_b25-ol-0-0-9303","first-page":"S11","article-title":"Managing toxicities of high-dose interleukin-2","volume":"16","author":"Schwartz","year":"2002","journal-title":"Oncology (Williston Park)"},{"key":"key20200714084003_b26-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/BF02974966","article-title":"Antitumor effects of human IL-15 gene modified lung cancer cell line","volume":"9","author":"Sheng","year":"1997","journal-title":"Chin J Cancer Res"},{"key":"key20200714084003_b27-ol-0-0-9303","first-page":"1197","article-title":"Inhibitory effects of recombinant human endostatin on growth and metastasis of lung adenocarcinoma LA795 in mice","volume":"21","author":"Xia","year":"2002","journal-title":"Ai Zheng"},{"key":"key20200714084003_b28-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00262-003-0449-9","article-title":"Complete tumor regressions induced by vaccination with IL-12 gene-transduced tumor cells in combination with IL-15 in a melanoma model in mice","volume":"53","author":"Lasek","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"key20200714084003_b29-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.it.2007.06.001","article-title":"TNF family ligands define niches for T cell memory","volume":"28","author":"Sabbagh","year":"2007","journal-title":"Trends Immunol"},{"key":"key20200714084003_b30-ol-0-0-9303","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.4049\/jimmunol.161.12.6977","article-title":"Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells","volume":"161","author":"Chapoval","year":"1998","journal-title":"J Immunol"},{"key":"key20200714084003_b31-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1073\/pnas.0902637106","article-title":"Waldmann: Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714084003_b32-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1158\/1078-0432.CCR-10-1966","article-title":"Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model","volume":"16","author":"Yu","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20200714084003_b33-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00000658-200201000-00011","article-title":"Hepatic resection for metastatic tumors from gastric cancer","volume":"235","author":"Okano","year":"2002","journal-title":"Ann Surg"},{"key":"key20200714084003_b34-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J Exp Med"},{"key":"key20200714084003_b35-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"key20200714084003_b36-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0065-2776(04)86006-1","article-title":"Interleukin-2, interleukin-15, and their roles in human natural killer cells","volume":"86","author":"Becknell","year":"2005","journal-title":"Adv Immunol"},{"key":"key20200714084003_b37-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/cmi.2013.8","article-title":"Memory NK cells: Why do they reside in the liver?","volume":"10","author":"Jiang","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"key20200714084003_b38-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.4049\/jimmunol.169.8.4153","article-title":"Enforced expression of Bcl-2 restores the number of NK cells, but does not rescue the impaired development of NKTcells or intraepithelial lymphocytes, in IL-2\/IL-15 receptor beta-chain-deficient mice","volume":"169","author":"Minagawa","year":"2002","journal-title":"J Immunol"},{"key":"key20200714084003_b39-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4049\/jimmunol.173.6.3594","article-title":"Cutting edge: Murine dendritic cells require IL-15Ralpha to prime NK cells","volume":"173","author":"Koka","year":"2004","journal-title":"J Immunol"},{"key":"key20200714084003_b40-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cyto.2012.06.017","article-title":"Regulating the Immune system via IL-15 Transpresentation","volume":"59","author":"Castillo","year":"2012","journal-title":"Cytokine"},{"key":"key20200714084003_b41-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ccr.2006.06.016","article-title":"Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment","volume":"10","author":"Budhu","year":"2006","journal-title":"Cancer Cell"},{"key":"key20200714084003_b42-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrc1979","article-title":"Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors","volume":"6","author":"Muller","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20200714084003_b43-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1592\/phco.31.8.813","article-title":"Cancer immunotherapy: Sipuleucel-T and beyond","volume":"31","author":"Hammerstrom","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key20200714084003_b44-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMra0708875","article-title":"Monoclonal antibody therapy for B-cell non-Hodgkin 7S lymphoma","volume":"359","author":"Cheson","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200714084003_b45-ol-0-0-9303","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri2073","article-title":"Prospects for the use of NK cells in immunotherapy of human cancer","volume":"7","author":"Ljunggren","year":"2007","journal-title":"Nat Rev Immunol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T10:04:37Z","timestamp":1693821877000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9303","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]}}}